TY  - GEN
AU  - Harris,L N
AU  - Liotcheva,V
AU  - Broadwater,G
AU  - Ramirez,M J
AU  - Maimonis,P
AU  - Anderson,S
AU  - Everett,T
AU  - Harpole,D
AU  - Moore,M B
AU  - Berry,D A
AU  - Rizzeri,D
AU  - Vredenburgh,J J
AU  - Bentley,R C
TI  - Comparison of methods of measuring HER-2 in metastatic breast cancer patients treated with high-dose chemotherapy
SN  - 0732-183X
PY  - 2001///0412
KW  - Adult
KW  - Aged
KW  - Antineoplastic Agents, Alkylating
KW  - pharmacology
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Biomarkers, Tumor
KW  - analysis
KW  - Breast Neoplasms
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Drug Resistance, Neoplasm
KW  - Female
KW  - Gene Expression Regulation, Neoplastic
KW  - Genes, erbB-2
KW  - genetics
KW  - Humans
KW  - In Situ Hybridization, Fluorescence
KW  - Middle Aged
KW  - Predictive Value of Tests
KW  - Prognosis
KW  - Receptor, ErbB-2
KW  - Retrospective Studies
N1  - Publication Type: Comparative Study; Journal Article
UR  - https://doi.org/10.1200/JCO.2001.19.6.1698
ER  -